Publikationen Prof. Dr. Christian Bogdan


Prof. Dr. med. Christian Bogdan

Publikationsliste Prof. Dr. Christian Bogdan

  1. Falkenhorst G, Remschmidt C, Harder T, Hummers-Pradier E, Wichmann O, Bogdan C. Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis. PloS one 2017;12:e0169368.
  2. Sektioglu IM, Carretero R, Bender N, et al. Macrophage-derived nitric oxide initiates T-cell diapedesis and tumor rejection. Oncoimmunology 2016;5:e1204506.
  3. Schleicher U, Paduch K, Debus A, et al. TNF-Mediated Restriction of Arginase 1 Expression in Myeloid Cells Triggers Type 2 NO Synthase Activity at the Site of Infection. Cell reports 2016;15:1062-75.
  4. Schey R, Dornhoff H, Baier JL, et al. CD101 inhibits the expansion of colitogenic T cells. Mucosal immunology 2016.
  5. Schatz V, Strussmann Y, Mahnke A, et al. Myeloid Cell-Derived HIF-1alpha Promotes Control of Leishmania major. J Immunol 2016;197:4034-41.
  6. Remschmidt C, Harder T, Wichmann O, Bogdan C, Falkenhorst G. Effectiveness, immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine revaccinations in the elderly: a systematic review. BMC infectious diseases 2016;16:711.
  7. Falkenhorst G, Remschmidt C, Harder T, et al. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2016;59:1623-57.
  8. Danzer C, Koller A, Baier J, et al. A mutation within the SH2 domain of slp-76 regulates the tissue distribution and cytokine production of iNKT cells in mice. European journal of immunology 2016.
  9. Brand A, Singer K, Koehl GE, et al. LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells. Cell metabolism 2016;24:657-71.
  10. Weinberger R, Falkenhorst G, Bogdan C, van der Linden M, Imohl M, von Kries R. Incidence of invasive pneumococcal disease in 5-15 year old children with and without comorbidities in Germany after the introduction of PCV13: Implications for vaccinating children with comorbidities. Vaccine 2015;33:6617-21.
  11. Stanger KM, Albert F, Kneser U, Bogdan C, Horch RE. Management of chronic osteomyelitis of the tibia with life-threatening complications under negative pressure wound therapy and isolation of Helcococcus kunzii. International wound journal 2015;12:443-6.
  12. Siegert I, Schodel J, Nairz M, et al. Ferritin-Mediated Iron Sequestration Stabilizes Hypoxia-Inducible Factor-1alpha upon LPS Activation in the Presence of Ample Oxygen. Cell reports 2015;13:2048-55.
  13. Jantsch J, Schatz V, Friedrich D, et al. Cutaneous Na+ storage strengthens the antimicrobial barrier function of the skin and boosts macrophage-driven host defense. Cell metabolism 2015;21:493-501.
  14. Hellenbrand W, Koch J, Harder T, et al. Background Paper for the update of meningococcal vaccination recommendations in Germany: use of the serogroup B vaccine in persons at increased risk for meningococcal disease. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2015;58:1314-43.
  15. Grankvist A, Moore ER, Svensson Stadler L, et al. Multi-locus sequence analysis (MLSA) of clinical "Candidatus Neoehrlichia mikurensis" strains from Europe. Journal of clinical microbiology 2015;pii: 10.1128/JCM.00880-15
  16. Fromm PD, Kling JC, Remke A, Bogdan C, Korner H. Fatal Leishmaniasis in the Absence of TNF Despite a Strong Th1 Response. Frontiers in microbiology 2015;6:1520.
  17. Christopoulos P, Dopfer EP, Malkovsky M, et al. A novel thymoma-associated immunodeficiency with increased naive T cells and reduced CD247 expression. J Immunol 2015;194:3045-53.
  18. Bogdan C, Steinkasserer A. Myeloid cells and the microenvironment, microorganisms and metabolism. Immunobiology 2015;220:iii.
  19. Wenneras C, Bloemberg G, Bogdan C. Reply to Raoult. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2014;59:1042-3.
  20. Stahl HC, Ahmadi F, Schleicher U, et al. A randomized controlled phase IIb wound healing trial of cutaneous leishmaniasis ulcers with 0.045% pharmaceutical chlorite (DAC N-055) with and without bipolar high frequency electro-cauterization versus intralesional antimony in Afghanistan. BMC infectious diseases 2014;14:619.
  21. Mahnke A, Meier RJ, Schatz V, et al. Hypoxia in Leishmania major skin lesions impairs the NO-dependent leishmanicidal activity of macrophages. The Journal of investigative dermatology 2014;134:2339-46.
  22. Jebran AF, Schleicher U, Steiner R, et al. Rapid healing of cutaneous leishmaniasis by high-frequency electrocauterization and hydrogel wound care with or without DAC N-055: a randomized controlled phase IIa trial in Kabul. PLoS neglected tropical diseases 2014;8:e2694 (*shared senior authorship; § corresponding authors).
  23. Hammon M, Kunz B, Dinzl V, et al. Practicability of hygienic wrapping of touchscreen operated mobile devices in a clinical setting. PloS one 2014;9:e106445.
  24. Grankvist A, Andersson PO, Mattsson M, et al. Infections with the tick-borne bacterium "Candidatus Neoehrlichia mikurensis" mimic noninfectious conditions in patients with B cell malignancies or autoimmune diseases. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2014;58:1716-22.
  25. Forstermann U, Bogdan C, Pfeilschifter JM, Mayer BM. Obituary. Nitric oxide : biology and chemistry / official journal of the Nitric Oxide Society 2014;40:99.
  26. Conrad E, Resch TK, Gogesch P, et al. Protection against RNA-induced liver damage by myeloid cells requires type I interferon and IL-1 receptor antagonist in mice. Hepatology 2014;59:1555-63.
  27. Bode SF, Bogdan C, Beutel K, et al. Hemophagocytic lymphohistiocytosis in imported pediatric visceral leishmaniasis in a nonendemic area. The Journal of pediatrics 2014;165:147-53 e1.
  28. Nairz M, Schleicher U, Schroll A, et al. Nitric oxide-mediated regulation of ferroportin-1 controls macrophage iron homeostasis and immune function in Salmonella infection. The Journal of experimental medicine 2013;210:855-73.
  29. Kaasch AJ, Rieg S, Kuetscher J, et al. Delay in the administration of appropriate antimicrobial therapy in Staphylococcus aureus bloodstream infection: a prospective multicenter hospital-based cohort study. Infection 2013;41:979-85.
  30. Jantsch J, Gerlach RG, Ensser A, et al. Severe soft tissue infection caused by a non-beta-hemolytic Streptococcus pyogenes strain harboring a premature stop mutation in the sagC gene. Journal of clinical microbiology 2013;51:1962-5.
  31. Haeberlein S, Fischer D, Thomas SM, Schleicher U, Beierkuhnlein C, Bogdan C. First assessment for the presence of phlebotomine vectors in Bavaria, Southern Germany, by combined distribution modeling and field surveys. PloS one 2013;8:e81088.
  32. Eichner S, Thoma-Uszynski S, Herrgott I, et al. Clinical complexity of Leishmania (Viannia) braziliensis infections amongst travelers. European journal of dermatology : EJD 2013;23:218-23.
  33. Butsch F, Faulde M, Debus A, Bogdan C, von Stebut E. Two cases of successful treatment of multilesional cutaneous leishmaniasis with liposomal amphotericin B. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2013;11:83-5.
  34. Auw-Hadrich C, Finke J, Serr A, Mittelviefhaus H, Bogdan C, Reinhard T. [Clarithromycin for monotherapy of B-cell MALT lymphoma?]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2013;110:1076-8.
  35. Anish C, Martin CE, Wahlbrink A, et al. Immunogenicity and diagnostic potential of synthetic antigenic cell surface glycans of Leishmania. ACS chemical biology 2013;8:2412-22.
  36. Wiese M, Gerlach RG, Popp I, et al. Hypoxia-mediated impairment of the mitochondrial respiratory chain inhibits the bactericidal activity of macrophages. Infection and immunity 2012;80:1455-66.
  37. Geissdorfer W, Moos V, Moter A, et al. High frequency of Tropheryma whipplei in culture-negative endocarditis. Journal of clinical microbiology 2012;50:216-22.
  38. Amann K, Bogdan C, Harrer T, Rech J. Renal leishmaniasis as unusual cause of nephrotic syndrome in an HIV patient. Journal of the American Society of Nephrology : JASN 2012;23:586-90.
  39. Prajeeth CK, Haeberlein S, Sebald H, Schleicher U, Bogdan C. Leishmania-infected macrophages are targets of NK cell-derived cytokines but not of NK cell cytotoxicity. Infection and immunity 2011;79:2699-708.
  40. Liesenfeld O, Parvanova I, Zerrahn J, et al. The IFN-gamma-inducible GTPase, Irga6, protects mice against Toxoplasma gondii but not against Plasmodium berghei and some other intracellular pathogens. PloS one 2011;6:e20568.
  41. Jantsch J, Wiese M, Schodel J, et al. Toll-like receptor activation and hypoxia use distinct signaling pathways to stabilize hypoxia-inducible factor 1alpha (HIF1A) and result in differential HIF1A-dependent gene expression. Journal of leukocyte biology 2011;90:551-62.
  42. Jantsch J, Schmidt B, Bardutzky J, Bogdan C, Eckardt KU, Raff U. Lethal varicella-zoster virus reactivation without skin lesions following renal transplantation. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2011;26:365-8.
  43. Wiese M, Castiglione K, Hensel M, Schleicher U, Bogdan C, Jantsch J. Small interfering RNA (siRNA) delivery into murine bone marrow-derived macrophages by electroporation. Journal of immunological methods 2010;353:102-10.
  44. von Loewenich FD, Geissdorfer W, Disque C, et al. Detection of "Candidatus Neoehrlichia mikurensis" in two patients with severe febrile illnesses: evidence for a European sequence variant. Journal of clinical microbiology 2010;48:2630-5.
  45. Haeberlein S, Sebald H, Bogdan* C, Schleicher* U. IL-18, but not IL-15, contributes to the IL-12-dependent induction of NK-cell effector functions by Leishmania infantum in vivo. European journal of immunology 2010;40:1708-17 (* shared senior authorship).
  46. Fritzsche C, Schleicher U, Bogdan C. Endothelial nitric oxide synthase limits the inflammatory response in mouse cutaneous leishmaniasis. Immunobiology 2010;215:826-32.
  47. Filipovic MR, Koh AC, Arbault S, et al. Striking inflammation from both sides: manganese(II) pentaazamacrocyclic SOD mimics act also as nitric oxide dismutases: a single-cell study. Angew Chem Int Ed Engl 2010;49:4228-32.
  48. Bussmeyer U, Sarkar A, Broszat K, et al. Impairment of gamma interferon signaling in human neutrophils infected with Anaplasma phagocytophilum. Infection and immunity 2010;78:358-63.
  49. Konig T, Bogdan* C, Schleicher* U. Translational repression of inducible NO synthase in macrophages by l-arginine depletion is not associated with an increased phosphorylation of eIF2alpha. Immunobiology 2009;214:822-7 (* shared senior authorship).
  50. Bogdan C, Schleicher U. Comment on "TLR9-dependent activation of dendritic cells by DNA from Leishmania major favors Th1 cell development and the resolution of lesions". J Immunol 2009;183:6859; author reply
  51. Valdez CA, Saavedra JE, Showalter BM, et al. Hydrolytic reactivity trends among potential prodrugs of the O2-glycosylated diazeniumdiolate family. Targeting nitric oxide to macrophages for antileishmanial activity. Journal of medicinal chemistry 2008;51:3961-70.
  52. Pelz K, Wiedmann-Al-Ahmad M, Bogdan C, Otten JE. Analysis of the antimicrobial activity of local anaesthetics used for dental analgesia. Journal of medical microbiology 2008;57:88-94.
  53. Kunz S, Oberle K, Sander A, Bogdan* C, Schleicher* U. Lymphadenopathy in a novel mouse model of Bartonella-induced cat scratch disease results from lymphocyte immigration and proliferation and is regulated by interferon-alpha/beta. The American journal of pathology 2008;172:1005-18 (* shared senior authorship).
  54. Fejer G, Drechsel L, Liese J, et al. Key role of splenic myeloid DCs in the IFN-alphabeta response to adenoviruses in vivo. PLoS pathogens 2008;4:e1000208.
  55. El Kasmi KC, Qualls JE, Pesce JT, et al. Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens. Nature immunology 2008;9:1399-406.
  56. Birkner K, Steiner B, Rinkler C, et al. The elimination of Anaplasma phagocytophilum requires CD4+ T cells, but is independent of Th1 cytokines and a wide spectrum of effector mechanisms. European journal of immunology 2008;38:3395-410.
  57. Unsoeld H, Mueller K, Schleicher U, et al. Abrogation of CCL21 chemokine function by transgenic over-expression impairs T cell immunity to local infections. International immunology 2007;19:1281-9.
  58. Schleicher U, Liese J, Knippertz I, et al. NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs. The Journal of experimental medicine 2007;204:893-906.
  59. Rocha FJ, Schleicher U, Mattner J, Alber G, Bogdan C. Cytokines, signaling pathways, and effector molecules required for the control of Leishmania (Viannia) braziliensis in mice. Infection and immunity 2007;75:3823-32.
  60. Lotz M, Konig T, Menard S, Gutle D, Bogdan C, Hornef MW. Cytokine-mediated control of lipopolysaccharide-induced activation of small intestinal epithelial cells. Immunology 2007;122:306-15.
  61. Liese J, Schleicher U, Bogdan C. TLR9 signaling is essential for the innate NK cell response in murine cutaneous leishmaniasis. European journal of immunology 2007;37:3424-34.
  62. Lechner A, Ritter U, Varona R, Marquez G, Bogdan C, Korner H. Protective immunity and delayed type hypersensitivity reaction are uncoupled in experimental Leishmania major infection of CCR6-negative mice. Microbes and infection / Institut Pasteur 2007;9:291-9.
  63. Goebel N, Serr A, Mittelviefhaus H, Reinhard T, Bogdan C, Auw-Haedrich C. Chlamydia psittaci, Helicobacter pylori and ocular adnexal lymphoma-is there an association? The German experience. Leukemia research 2007;31:1450-2.
  64. Glocker E, Bogdan C, Kist M. Characterization of rifampicin-resistant clinical Helicobacter pylori isolates from Germany. The Journal of antimicrobial chemotherapy 2007;59:874-9.
  65. Weighardt H, Kaiser-Moore S, Schlautkotter S, et al. Type I IFN modulates host defense and late hyperinflammation in septic peritonitis. J Immunol 2006;177:5623-30.
  66. Scorpio DG, von Loewenich FD, Gobel H, Bogdan C, Dumler JS. Innate immune response to Anaplasma phagocytophilum contributes to hepatic injury. Clinical and vaccine immunology : CVI 2006;13:806-9.
  67. Mattner J, Donhauser N, Werner-Felmayer G, Bogdan C. NKT cells mediate organ-specific resistance against Leishmania major infection. Microbes and infection / Institut Pasteur 2006;8:354-62.
  68. Lotz M, Gutle D, Walther S, Menard S, Bogdan C, Hornef MW. Postnatal acquisition of endotoxin tolerance in intestinal epithelial cells. The Journal of experimental medicine 2006;203:973-84.
  69. Blaich A, Hellwig B, Bogdan C. [Tetanus following an abrasion injury]. Dtsch Med Wochenschr 2006;131:979-81.
  70. Wilhelm P, Wiede F, Meissner A, Donhauser N, Bogdan C, Korner H. TNF but not Fas ligand provides protective anti-L. major immunity in C57BL/6 mice. Microbes and infection / Institut Pasteur 2005;7:1461-8.
  71. Weitzel T, Muhlberger N, Jelinek T, et al. Imported leishmaniasis in Germany 2001-2004: data of the SIMPID surveillance network. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2005;24:471-6.
  72. Scorpio DG, Von Loewenich FD, Bogdan C, Dumler JS. Innate immune tissue injury and murine HGA: tissue injury in the murine model of granulocytic anaplasmosis relates to host innate immune response and not pathogen load. Annals of the New York Academy of Sciences 2005;1063:425-8.
  73. Schleicher U, Hesse A, Bogdan C. Minute numbers of contaminant CD8+ T cells or CD11b+CD11c+ NK cells are the source of IFN-gamma in IL-12/IL-18-stimulated mouse macrophage populations. Blood 2005;105:1319-28.
  74. Rinkler C, Kern Y, Bogdan C, Von Loewenich FD. Mechanisms of immunological control of Anaplasma phagocytophilum in mice. Annals of the New York Academy of Sciences 2005;1063:411-2.
  75. von Loewenich FD, Scorpio DG, Reischl U, Dumler JS, Bogdan C. Frontline: control of Anaplasma phagocytophilum, an obligate intracellular pathogen, in the absence of inducible nitric oxide synthase, phagocyte NADPH oxidase, tumor necrosis factor, Toll-like receptor (TLR)2 and TLR4, or the TLR adaptor molecule MyD88. European journal of immunology 2004;34:1789-97.
  76. Schleicher U, Mattner J, Blos M, et al. Control of Leishmania major in the absence of Tyk2 kinase. European journal of immunology 2004;34:519-29.
  77. Ritter U, Mattner J, Rocha JS, Bogdan* C, Korner* H. The control of Leishmania (Leishmania) major by TNF in vivo is dependent on the parasite strain. Microbes and infection / Institut Pasteur 2004;6:559-65 (*shared senior authorship).
  78. Mattner J, Wandersee-Steinhauser A, Pahl A, et al. Protection against progressive leishmaniasis by IFN-beta. J Immunol 2004;172:7574-82.
  79. Von Loewenich FD, Stumpf G, Baumgarten BU, Rollinghoff M, Dumler JS, Bogdan C. A case of equine granulocytic ehrlichiosis provides molecular evidence for the presence of pathogenic anaplasma phagocytophilum (HGE agent) in Germany. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2003;22:303-5.
  80. Von Loewenich FD, Stumpf G, Baumgarten BU, Rollinghoff M, Dumler JS, Bogdan C. Human granulocytic ehrlichiosis in Germany: evidence from serological studies, tick analyses, and a case of equine ehrlichiosis. Annals of the New York Academy of Sciences 2003;990:116-7.
  81. von Loewenich FD, Baumgarten BU, Schroppel K, Geissdorfer W, Rollinghoff M, Bogdan C. High diversity of ankA sequences of Anaplasma phagocytophilum among Ixodes ricinus ticks in Germany. Journal of clinical microbiology 2003;41:5033-40.
  82. Karaghiosoff M, Steinborn R, Kovarik P, et al. Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock. Nature immunology 2003;4:471-7.
  83. Geissdorfer W, Bohmer C, Pelz K, Schoerner C, Frobenius W, Bogdan C. Tuboovarian abscess caused by Atopobium vaginae following transvaginal oocyte recovery. Journal of clinical microbiology 2003;41:2788-90.
  84. El-Gayar S, Thuring-Nahler H, Pfeilschifter J, Rollinghoff M, Bogdan C. Translational control of inducible nitric oxide synthase by IL-13 and arginine availability in inflammatory macrophages. J Immunol 2003;171:4561-8.
  85. Blos M, Schleicher U, Soares Rocha FJ, Meissner U, Rollinghoff M, Bogdan C. Organ-specific and stage-dependent control of Leishmania major infection by inducible nitric oxide synthase and phagocyte NADPH oxidase. European journal of immunology 2003;33:1224-34.
  86. Qadoumi M, Becker I, Donhauser N, Rollinghoff M, Bogdan C. Expression of inducible nitric oxide synthase in skin lesions of patients with american cutaneous leishmaniasis. Infection and immunity 2002;70:4638-42.
  87. Menges M, Rossner S, Voigtlander C, et al. Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. The Journal of experimental medicine 2002;195:15-21.
  88. Wilhelm P, Ritter U, Labbow S, et al. Rapidly fatal leishmaniasis in resistant C57BL/6 mice lacking TNF. J Immunol 2001;166:4012-9.
  89. Schroppel K, Kryk M, Herrmann M, Leberer E, Rollinghoff M, Bogdan C. Suppression of type 2 NO-synthase activity in macrophages by Candida albicans. International journal of medical microbiology : IJMM 2001;290:659-68.
  90. Schindler H, Lutz MB, Rollinghoff M, Bogdan C. The production of IFN-gamma by IL-12/IL-18-activated macrophages requires STAT4 signaling and is inhibited by IL-4. J Immunol 2001;166:3075-82.
  91. Geissdorfer W, Wittmann I, Seitz G, et al. A case of aortic valve disease associated with Tropheryma whippelii infection in the absence of other signs of Whipple's disease. Infection 2001;29:44-7.
  92. Geissdorfer W, Wittmann I, Rollinghoff M, Schoerner C, Bogdan C. Detection of a new 16S-23S rRNA spacer sequence variant (type 7) of Tropheryma whippelii in a patient with prosthetic aortic valve endocarditis. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2001;20:762-3.
  93. Bogdan C, Schonian G, Banuls AL, et al. Visceral leishmaniasis in a German child who had never entered a known endemic area: case report and review of the literature. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;32:302-6.
  94. Xaus J, Comalada M, Valledor AF, et al. LPS induces apoptosis in macrophages mostly through the autocrine production of TNF-alpha. Blood 2000;95:3823-31.
  95. Mattner J, Schindler H, Diefenbach A, Rollinghoff M, Gresser I, Bogdan C. Regulation of type 2 nitric oxide synthase by type 1 interferons in macrophages infected with Leishmania major. European journal of immunology 2000;30:2257-67.
  96. Landmann E, Bogdan C, Donhauser N, Artlich A, Staude B, Gortner L. [Leishmaniasis with cutaneous and visceral involvement in a 13-month old boy]. Klinische Padiatrie 2000;212:266-7.
  97. Karaghiosoff M, Neubauer H, Lassnig C, et al. Partial impairment of cytokine responses in Tyk2-deficient mice. Immunity 2000;13:549-60.
  98. Bogdan C, Donhauser N, Doring R, Rollinghoff M, Diefenbach A, Rittig MG. Fibroblasts as host cells in latent leishmaniosis. The Journal of experimental medicine 2000;191:2121-30.
  99. Schluter D, Deckert-Schluter M, Lorenz E, Meyer T, Rollinghoff M, Bogdan C. Inhibition of inducible nitric oxide synthase exacerbates chronic cerebral toxoplasmosis in Toxoplasma gondii-susceptible C57BL/6 mice but does not reactivate the latent disease in T. gondii-resistant BALB/c mice. J Immunol 1999;162:3512-8.
  100. Diefenbach A, Schindler H, Rollinghoff M, Yokoyama WM, Bogdan C. Requirement for type 2 NO synthase for IL-12 signaling in innate immunity. Science 1999;284:951-5.
  101. Baumgarten BU, Rollinghoff M, Bogdan C. Prevalence of Borrelia burgdorferi and granulocytic and monocytic ehrlichiae in Ixodes ricinus ticks from southern Germany. Journal of clinical microbiology 1999;37:3448-51.
  102. Stenger S, Hanson DA, Teitelbaum R, et al. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 1998;282:121-5.
  103. Schindler H, Diefenbach A, Rollinghoff M, Bogdan C. IFN-gamma inhibits the production of latent transforming growth factor-beta1 by mouse inflammatory macrophages. European journal of immunology 1998;28:1181-8.
  104. Rittig MG, Schroppel K, Seack KH, et al. Coiling phagocytosis of trypanosomatids and fungal cells. Infection and immunity 1998;66:4331-9.
  105. Diefenbach A, Schindler H, Donhauser N, et al. Type 1 interferon (IFNalpha/beta) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity 1998;8:77-87.
  106. Weiss G, Bogdan C, Hentze MW. Pathways for the regulation of macrophage iron metabolism by the anti-inflammatory cytokines IL-4 and IL-13. J Immunol 1997;158:420-5.
  107. Bogdan C, Thuring H, Dlaska M, Rollinghoff M, Weiss G. Mechanism of suppression of macrophage nitric oxide release by IL-13: influence of the macrophage population. J Immunol 1997;159:4506-13.
  108. Bogdan C, Kern P, Richter E, et al. Systemic infection with Mycobacterium genavense following immunosuppressive therapy in a patient who was seronegative for human immunodeficiency virus. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;24:1245-7.
  109. Stenger S, Donhauser N, Thuring H, Rollinghoff M, Bogdan C. Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase. The Journal of experimental medicine 1996;183:1501-14.
  110. Blank C, Bogdan C, Bauer C, Erb K, Moll H. Murine epidermal Langerhans cells do not express inducible nitric oxide synthase. European journal of immunology 1996;26:792-6.
  111. Vodovotz Y, Russell D, Xie QW, Bogdan C, Nathan C. Vesicle membrane association of nitric oxide synthase in primary mouse macrophages. J Immunol 1995;154:2914-25.
  112. Thuring H, Stenger S, Gmehling D, Rollinghoff M, Bogdan C. Lack of inducible nitric oxide synthase activity in T cell clones and T lymphocytes from naive and Leishmania major-infected mice. European journal of immunology 1995;25:3229-34.
  113. Stenger S, Thuring H, Rollinghoff M, Manning P, Bogdan C. L-N6-(1-iminoethyl)-lysine potently inhibits inducible nitric oxide synthase and is superior to NG-monomethyl-arginine in vitro and in vivo. European journal of pharmacology 1995;294:703-12.
  114. Bogdan C, Werner E, Stenger S, Wachter H, Rollinghoff M, Werner-Felmayer G. 2,4-Diamino-6-hydroxypyrimidine, an inhibitor of tetrahydrobiopterin synthesis, downregulates the expression of iNOS protein and mRNA in primary murine macrophages. FEBS letters 1995;363:69-74.
  115. Stenger S, Thuring H, Rollinghoff M, Bogdan C. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. The Journal of experimental medicine 1994;180:783-93.
  116. Bogdan C, Vodovotz Y, Paik J, Xie QW, Nathan C. Mechanism of suppression of nitric oxide synthase expression by interleukin-4 in primary mouse macrophages. Journal of leukocyte biology 1994;55:227-33.
  117. Vodovotz* Y, Bogdan* C, Paik J, Xie QW, Nathan C. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta. The Journal of experimental medicine 1993;178:605-13 (*shared first authorship).
  118. Hoerauf A, Richter K, Bogdan C, Röllinghoff M, Solbach W. Viszerale Leishmaniose als Ursache von Splenomegalie, Fieber und Panzytopenie bei einem 6-jährigen deutschen Mädchen. Fortschr antimikrob antineoplast Chemotherapie 1993;12/1:381-6.
  119. Bogdan C, Vodovotz Y, Paik J, Xie QW, Nathan C. Traces of bacterial lipopolysaccharide suppress IFN-gamma-induced nitric oxide synthase gene expression in primary mouse macrophages. J Immunol 1993;151:301-9.
  120. Stosiek N, Bogdan C, Solbach W, Hornstein OP. [Leishmaniasis with multiple cutaneous nodules]. Dtsch Med Wochenschr 1992;117:1752-6.
  121. Murray HW, Squires KE, Miralles CD, et al. Acquired resistance and granuloma formation in experimental visceral leishmaniasis. Differential T cell and lymphokine roles in initial versus established immunity. J Immunol 1992;148:1858-63.
  122. Bogdan C, Paik J, Vodovotz Y, Nathan C. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10. The Journal of biological chemistry 1992;267:23301-8.
  123. Bogdan C, Ding A. Taxol, a microtubule-stabilizing antineoplastic agent, induces expression of tumor necrosis factor alpha and interleukin-1 in macrophages. Journal of leukocyte biology 1992;52:119-21.
  124. Bogdan* C, Vodovotz* Y, Nathan C. Macrophage deactivation by interleukin 10. The Journal of experimental medicine 1991;174:1549-55 (*shared first authorship).
  125. Bogdan C, Stenger S, Rollinghoff M, Solbach W. Cytokine interactions in experimental cutaneous leishmaniasis. Interleukin 4 synergizes with interferon-gamma to activate murine macrophages for killing of Leishmania major amastigotes. European journal of immunology 1991;21:327-33.
  126. Moll H, Binoder K, Bogdan C, Solbach W, Rollinghoff M. Production of tumour necrosis factor during murine cutaneous leishmaniasis. Parasite immunology 1990;12:483-94.
  127. Bogdan C, Stosiek N, Fuchs H, Rollinghoff M, Solbach W. Detection of potentially diagnostic leishmanial antigens by western blot analysis of sera from patients with kala-azar or multilesional cutaneous leishmaniasis. The Journal of infectious diseases 1990;162:1417-8.
  128. Bogdan C, Schroppel K, Lohoff M, Rollinghoff M, Solbach W. Immunization of susceptible hosts with a soluble antigen fraction from Leishmania major leads to aggravation of murine leishmaniasis mediated by CD4+ T cells. European journal of immunology 1990;20:2533-40.
  129. Bogdan C, Moll H, Solbach W, Rollinghoff M. Tumor necrosis factor-alpha in combination with interferon-gamma, but not with interleukin 4 activates murine macrophages for elimination of Leishmania major amastigotes. European journal of immunology 1990;20:1131-5.
  130. Bogdan C, Streck H, Rollinghoff M, Solbach W. Cyclosporin A enhances elimination of intracellular L. major parasites by murine macrophages. Clinical and experimental immunology 1989;75:141-6.
  131. Bogdan C. Medizinerausbildung in England - ein Erfahrungsaustausch und Beitrag zur Diskussion um die Verbesserung der Situation an den deutschen medizinischen Hochschulen. Medizin Mensch Gesellschaft 1989:277-28.
  132. Streck H, Bogdan C, Tingle A, Rollinghoff M. Murine cutaneous leishmaniasis: comparative study on the capacity of macrophages from "healer" and "non-healer" mouse strains to control L. tropica replication. Zentralblatt fur Bakteriologie, Mikrobiologie, und Hygiene Series A, Medical microbiology, infectious diseases, virology, parasitology 1987;263:594-604.
  133. Solbach W, Forberg K, Kammerer E, Bogdan C, Rollinghoff M. Suppressive effect of cyclosporin A on the development of Leishmania tropica-induced lesions in genetically susceptible BALB/c mice. J Immunol 1986;137:702-7.